CEL-SCI Corp (AMEX:CVM)
CAPS Rating:
The Company engages in the research and development of drugs and vaccines. Its most advanced product, Multikine, manufactured using the Company's proprietary cell culture technologies, is being developed for the treatment of cancer.
RSS Headlines
Fool UK